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Highlights of the HMA Scientific Session
Russell T. Stodd MD
MEDICINE FOR THE NEW MILLENNIUM
The outstanding continuing education program for this annual
meeting was divided into four sections, basic science, clinical
neuroscience, the bionic man: implants and prosthetics, and organ
and tissue transplantation.
BASIC SCIENCE UPDATE - Friday, October 29,
1999-
The first basic science offering featured a detailed discussion of
Hypercoagulabile States - What Should Be Done? by Dr. Stacey
Honda, pathologist and assistant clinical professor at the John A.
Burns School of Medicine. Noting that venous thromboembolism
is the 3rd most common cardiovascular disorder, following ischemic
heart disease and stroke, she elaborated on the three causes; inher
ited, acquired and physiologic. Her comprehensive presentation
localized primarily around the inherited defects with ethnic varia
tions. The talk was delivered rapidly with multiple detailed slides.
Nadhipuram V. Bhagavan, Ph.D. ,Professor and Chairman of the
Department of Biochemistry and Biophysics at JABSM, followed
with a discussion of Prostate Specific Antigen (PSA) What To Do?
Prostate cancer is the leading cancer site in men with 179,000 new
cases in 1999. PSA is the best tumor marker thus far, but that very
sensitivity creates questions. This glycoprotein serine protease is
found in small concentrations in other tissues, both benign and
malignant. Noting that 20% of men with prostate cancer have
normal PSAs, and that possibly more men die with prostate cancer
than from it, Dr. Bhagavan concluded his excellent presentation
with a stimulating question and answer session. Interesting and
compelling presentation.
A rousing round of applause greeted the next speaker, Ryuzo
Yanagimachi, Ph.D., the noted professor, who presented a program
about Cloning of a Mouse - What Does This Scientific Breakthrough
Mean? Using slides of various animals, mice, sheep, cattle, goat,
pig, and even the wooly mammoth, Dr. Yanagimachi discussed
questions of public acceptance, and possible uses of cloning. People
are very favorable to cloning of animals to benefit our society, but
99% of those polled are against human cloning. His accent was
evident, but the presentation was witty, informative, personable and
altogether captivating.
FOCUS OF CLINICAL NEUROSCIENCE
The second session shifted to a focus on clinical neuroscience by
Cherylee W.J. Chang, M.D. Director of the Stroke Center at Queen’s
Medical Center. Using slides and a comprehensive handout, Dr.
Chang presented a very good discussion of Stroke as a Brain Attack
—
What Is Important and Why the Rush? She noted that 3/4 million
Americans are hit with stroke each year at a cost of $41 billion.
Nationally 85% are ischemic and 15% hemorrhagic, while in
Hawaii the ratio is 70/30. The reason for this disparity has not been
determined. Dr. Chang emphasized the value of early diagnosis and
treatment. It is essential to have a coordinated team approach with
prompt 911 response, EMS and hospital personnel ready to provide
necessary support, with CT scans, thrombolytics, anti-coagulants,
neuroprotectors, and possibly neurointerventional radiologists. With
a ready and trained team, we will be able to decrease the morbidity
of this disabling condition. This was valuable material, well
presented.
Eric M. Oshiro, M.D. Honolulu neurologic surgeon, followed
with a paper on Head and SpinalCord Injury in Hawaii - We Can Do
Better. He noted the need for prompt support with oxygen and
maintenance of blood pressure in patients presenting in coma. High
doses of steroids are often needed, and close observation for pro
gressive neurologic deterioration, with signs of intracranial hyper
tension. Management of acute spinal cord injuries require identifi
cation, stabilization, and immobilization with appropriate devices.
Therapy with high dose steroids, oxygen and support of blood
pressure are again the primary consideration.
The final paper of the morning was a Continuum of Neurological
Care in Hawaii, presented by Jill Williams, M.D. Physical Medicine
and Rehabilitation of the Rehabilitation Hospital of the Pacific.
Focusing on development to fullest potential after stroke or injury,
Dr. Williams showed how patients are aided in speech recovery,
managing deformities, proper exercise, and learning how to care for
themselves. The physician’s role is to manage pain, insomnia,
spasticity and depression. Occupational therapy can be provided,
and family members are educated and instructed in how to assist the
patient in recovery and adaptation. Coordinated planning and
efforts can result in optimal development and rehabilitation.
THE BIONIC MAN - PROSTHETICS AND IM
PLANTS. Saturday, October 30, 1999
The morning session began with a presentation of Joint Implants by
Thomas J. Kane III, M.D., Chief, Section of Joint Implant Surgery
at JABSM. Describing implants of shoulder, hip and knee, he noted
the biologic structure of cartilage and its healing structure fibro
cartilage. Research has led to replacement of fibro-cartilage with
autologous tissue which can be harvested, grown in a lab and
replaced to aid return to normal function. Regarding implants,
material may be ceramic, polyethylene, and cobalt chrome, vari
ously resistant to degeneration in time. New synthetics are con
stantly being studied for bio-tolerance and durability. Some joints
can be well replaced such as hip and knee, and the shoulder
somewhat less effectively, however the wrist and ankle joint im
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plants are much less successful. The primary indication for joint
replacement is pain, and secondarily, mobility. At present, about
400,000 hip replacements are performed in America each year, with
longevity of about 15 years.
Cataract Surgery and Intraocular Lens Implantation by Carlos A.
Omphroy, M.D., Assistant Clinical Professor Surgery at JABSM
centered around a careful history and evolution of cataract surgery
with good slide illustrations. The development of intraocular lens
implantation began almost 50 years ago by Dr. Harold Ridley in
Great Britain. Subsequently, various implants were described and
evolved, with variable degrees of success, so that acceptance awaited
an implant that could be well tolerated. Today, cataract surgery is
the most common operation performed with over two million
surgeries each year. The operation is a purely ambulatory procedure
with a high degree of successful outcome, and great savings in
patient morbidity, and vast reduction in expenditures.
Clyde H. Ishii, M.D., Clinical Associate Professor of Surgery,
John A. Bums School ofMedicine, presented a paper on Implants in
Plastic Surgery. With an excellent printed outline, he noted the
history of plastic surgery, and that the word comes from the Greek,
plastikos - “to mold.” Biocompatibility and implant toxicity are
matters of great importance, and the surgeon’s skill and location of
implant are factors. Systemic disease, hypersensitivity, and carci
nogenicity are rarely associated with current polymeric and metal
implants. Primary causes of failure are infection, extrusion, pain,
loosening, displacement, fracture, implant degradation and inflam
mation. All synthetic polymers stimulate fibrous encapsulation.
Implants have proved successful for the nose, cheek, chin, breasts,
joints, teeth, and bone. The future will yield implants of longer
duration and bioresorbable polymers where tissue will gradually
replace the artificial one.
Edward N. Shen, M.D. Professor and Chief of Cardiology at the
JABSM followed with a paper on Cardiac Implants and Prosthetics.
The latest stents can open vessels and save a lot of surgery in
cardiovascular disease, even for large vessel stenosis. Hospitaliza
tions can be reduced from seven to two days. Prosthetic heart valves
were discussed, as were pacemakers and defibrillators. Minification
of devices has rendered them much more versatile for heart failure
and other cardiac myopathies. The artificial heart is still on the
horizon. No handouts were included.
A marvelous presentation of the Bionic Man: Implants and
Prosthetics ofcochlear implants for severely deafpatients was given
by Kazuo Teruya, M.D. Associate Clinical Professor of Surgery at
JABSM. With appropriate illustrations, the procedure was de
scribed to show the cochlear implant, an electronic device not a
hearing aid, surgically implanted in the cochlea to stimulate the
nerve endings directly. Performance varies, and rehabilitation in
auditory and speech therapy is extremely important. Dr. Teruya
presented two patients who described their success with the cochlear
implant in a dramatic and refreshing manner. An excellent program.
The session concluded with the Bionic Lower Limb, by Gary A.
Okamoto, M.D. AssociateClinical ProfessorofMedicine atJABSM.
The oldest prosthesis was found in a tomb in Capua, Italy dating to
300 B.C. and was made of bronze and iron with a wooden core.
Stimulated by wars and other trauma, serious research and develop
ment accelerated with World War II. Over the last three decades an
explosive growth in prosthetics has occurred. Dr. Okamoto’ s
presentation included a comprehensive handout and a video and
slides. Various devices for amputees were illustrated, and the
subject was well covered with illustrations of walking, running, and
athletic competition.
ORGAN AND TISSUE TRANSPLANTATION
-
Sunday, October 31, 1999.
The final educational session began with a presentation of Organ
Retrieval: Hawaii’s Experience and How to Increase Donations by
Robyn Kaufman, Executive Director, Organ Donor Center of Ha
waii. Presently, 225 patients are awaiting organ transplant in Ha
waii. Donors are difficult to get in Hawaii due to relatively small
numbers and problems with gaining consent. When death of a
potential donor is imminent, the organ donor center should be
contacted. Brain death needs to be determined and consent of the
family obtained. The time of approach to the family of the donor
must be considered when asking for consent to donate organs,
irrespective of the dying person’s wishes.
Fred Safi, Eye Bank Director for the Hawaii Lions Eye Bank and
Makana Foundation, gave a paper, Cornea and Eye Retrieval sum
marizing retheval ofeyes for comeal transplant and scieral banking.
He noted that the first comeal transplant was attempted in 1905, and
is now a common and successful procedure. Tissue typing is not
necessary, and rejection is uncommon. Whenever possible the tissue
should be harvested in four to six hours, and can be maintained in
preservative solution for up to five days.
Renal Transplantation was presented by Whitney M. L. Limm,
M.D., Associate Professor of Surgery JABSM. The first successful
kidney transplants occurred in the 1960s, and are now done rou
tinely. In 1998, twelve thousand renal transplants were performed
in the United States. The failure rate is between 10 and 15% in the
first year, due to death or tissue rejection. After one year the problem
is chronic rejection or death. Steroids and immunosuppression
drugs are used, and the future offers more precise DNA testing and
better drugs to prevent rejection.
Liver Transplantation for end stage liver disease was discussed by
Linda L. Wong, M.D., Assistant Clinical Professor at JABSM. The
procedure, once considered impossible, has become a standard
operation at transplant centers. The first year survival is 79%, three
year 67% and five year 62%. The primary reasons for liver failure
are hepatitis B, C, or alcoholic cirrhosis. There are more patients
than donor livers, so the question arises who gets the liver? Patients
are rated from one to four according to severity of illness, but that
rationality is being challenged. Arguably, the sickest patients often
have the worst prognosis, therefore perhaps the liver should go to the
healthier patient with the best chance of survival. Also, factors such
as politics, wealth, and fame, such as the Mickey Mantle episode can
enter in, but an allocation scheme is used whenever possible.
Carlos Moreno-Cabral, M.D., Assistant Professor of Surgery at
JABSM gave an excellent paper on Cardiac Transplantation.
Christiaan Barnard in South Africa performed the first cardiac
transplant in 1967. Dr. Norman Shumway at Stanford pioneered the
procedure in America in 1968, and now there are 304 transplant
programs and 48,451 heart operations have been performed. Over
all the survival rate at one year is 79%, and the median survival is 8.8
years. The program was initiated at St. Francis Hospital in March
1987, and as of September 1999, 32 transplants have been done with
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three hospitals deaths. The approximate cost is $150,000, and the
longest survivor is beyond 10 years. Donor availability remains the
main limiting factor. Dr. Cabral presented current research in
ventricular assist devices, and outlined some future expectations in
cardiac devices.
Controversies in Organ Donation and Transplantation was the
topic for Alan H.S. Cheung, M.D., Professor of Surgery at JABSM.
New technology has brought controversies as the question of organ
replacement has opened many areas of challenge. When should a
transplant be done? Who should receive the tissue? What about
using the tissue of anencephalic infants, prisoners, and what about
the use of xenotransplants from animals? Now the internet offers the
possibility of buying donor organs. As this field expands how can
the escalating costs of harvesting donor organs, performing surgery
and immunosuppresive drugs be funded? Many questions and some
conflicts attend this burgeoning area of medical technology, and
structure and appropriate mechanisms need to be discussed and
planned.
The program drew to a close with a paper on Bone Marrow
Transplantation Update by Kaye Kawahara, M.D. Director of Bone
Marrow Transplantation at St. Francis Medical Center. Sources of
stem cells for transplant are bone marrow, peripheral blood, and
cord blood. The procedure is reserved for those patient’s suffering
with diseases that have little chance for survival such as some of the
leukemias, lymphomas and advanced breast cancer. The procedure
has been challenged by reports of recent research which indicate that
bone marrow transplant has proved no more effective than standard
cancer therapy. Part of the difficulty is that there is no way to run a
randomized study. Future directions include gene therapy, graft
manipulation and stem cell selection.
ScientWc Session at the 1999 HMA Annual Meeting.
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